EU Parliament OKs Law Ending Validity Of Centralized Drug Approvals In Northern Ireland
Giving the UK regulator the power to issue UK-wide marketing authorizations for products that fall within the scope of the EU centralized procedure will reduce the regulatory burden on companies marketing medicines in Northern Ireland.